Seeking men and women aged 18 and older who have been hospitalized for COVID-19 for a study of an experimental treatment using Hyperimmune Intravenous Immunoglobulin containing antibodies for COVID-19.
We are studying an experimental treatment using hyperimmune Intravenous Immunoglobulin that contains antibodies against the virus that causes COVID-19 to see if it helps hospitalized adults recovery more quickly. Half of the study participants will receive the investigational drug and half will receive a placebo that looks like the investigational drug but doesn't contain any medicine. All participants will also receive treatment with the drug Remdesivir.
What we're hoping for
We hope to evaluate whether the experimental treatment using hyperimmune intravenous immunoglobulin containing antibodies for COVID-19 helps people hospitalized with COVID-19 recover more quickly.
ClinicalTrials.gov Identifier: NCT04546581